Skip to main content
Log in

Does CT Influence the Decision to Perform Colectomy in Patients with Severe Ulcerative Colitis?

  • original article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Purpose

The purpose of this study was to evaluate the impact of abdominal computerized tomography (CT) on the decision to perform colectomy in patients with severe acute ulcerative colitis (SAC).

Methods

Patients with SAC admitted to a single hospital between 2002 and 2007 were reviewed. The criteria for SAC were ≥6 bloody bowel movements per day plus fever >37.8°C, pulse >90, or hemoglobin <10.5 g/dL. Study patients were given a SAC score of 2–4 based on these criteria. Clinical and laboratory parameters, medication use, abdominal X-ray, and endoscopic findings in SAC patients who did or did not have an abdominal CT were compared. Chi-squared, Fisher exact test, and Wilcoxon rank sum test were used as appropriate.

Results

Ninety-two consecutive patients with SAC were evaluated. CT was performed in 26 (28%). The SAC score, laboratory values, abdominal X-ray, and endoscopic findings were similar in patients who did or did not have a CT. Colectomy was performed in 32 (48%) and 10 (38%) patients who did or did not have a CT, respectively (p = 0.4). The CT findings were similar in patients who required colectomy and those who did not require colectomy. In two (8%) of the patients who underwent CT, the CT findings clearly influenced the decision to perform or defer colectomy.

Conclusion

CT has a minor impact on the decision to perform colectomy in patients with severe acute ulcerative colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38(6):905–910. doi:10.1136/gut.38.6.905.

    Article  PubMed  CAS  Google Scholar 

  2. Prantera C, Lorenzetti R, Cerro P, Davoli M, Brancato G, Fanucci A. The plain abdominal film accurately estimates extent of active ulcerative colitis. J Clin Gastroenterol. 1991;13(2):231–234.

    PubMed  CAS  Google Scholar 

  3. Carbonnel F, Lavergne A, Lemann M, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci. 1994;39(7):1550–1557. doi:10.1007/BF02088063.

    Article  PubMed  CAS  Google Scholar 

  4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. BMJ. 1955;2(4947):1041–1048.

    Article  PubMed  CAS  Google Scholar 

  5. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985;89(5):1005–1013.

    PubMed  CAS  Google Scholar 

  6. Rosenberg W, Ireland A, Jewell DP. High-dose methylprednisolone in the treatment of active ulcerative colitis. J Clin Gastroenterol. 1990;12(1):40–41. doi:10.1097/00004836-199002000-00011.

    Article  PubMed  CAS  Google Scholar 

  7. D’Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001;120(6):1323–1329. doi:10.1053/gast.2001.23983.

    Article  PubMed  CAS  Google Scholar 

  8. Jakobovits SL, Jewell DP, Travis SP. Infliximab for the treatment of ulcerative colitis: outcomes in oxford from 2000 to 2006. Aliment Pharmacol Ther. 2007;25(9):1055–1060.

    Article  PubMed  CAS  Google Scholar 

  9. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128(7):1805–1811. doi:10.1053/j.gastro.2005.03.003.

    Article  PubMed  CAS  Google Scholar 

  10. Probert CS, Hearing SD, Schreiber S, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomized controlled trial. Gut. 2003;52(7):998–1002. doi:10.1136/gut.52.7.998.

    Article  PubMed  CAS  Google Scholar 

  11. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462–2476. doi:10.1056/NEJMoa050516.

    Article  PubMed  CAS  Google Scholar 

  12. Van Assche G, D’Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology. 2003;125(4):1025–1031. doi:10.1016/S0016-5085(03)01214-9.

    Article  PubMed  Google Scholar 

  13. Lewis JD, Lichtenstein GR, Deren JJ, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008;134(3):688–695.

    PubMed  CAS  Google Scholar 

  14. Plevy S, Salzberg B, Van Assche G, et al. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007;133(5):1414–1422. doi:10.1053/j.gastro.2007.08.035.

    Article  PubMed  CAS  Google Scholar 

  15. Schreiber S, Keshavarzian A, Isaacs KL, et al. A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology. 2007;132(1):76–86. doi:10.1053/j.gastro.2006.11.029.

    Article  PubMed  CAS  Google Scholar 

  16. Van Assche G, Sandborn WJ, Feagan BG, et al. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomized, double blind, placebo controlled, dose ranging trial. Gut. 2006;55(11):1568–1574. doi:10.1136/gut.2005.089854.

    Article  PubMed  CAS  Google Scholar 

  17. Ogata H, Matsui T, Nakamura M, et al. A randomized dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut. 2006;55(9):1255–1262. doi:10.1136/gut.2005.081794.

    Article  PubMed  CAS  Google Scholar 

  18. Vogel J, da Luz Moreira A, Baker M, et al. CT enterography for Crohn’s disease: accurate preoperative diagnostic imaging. Dis Colon Rectum. 2007;50(11):1761–1769. doi:10.1007/s10350-007-9005-6.

    Article  PubMed  Google Scholar 

  19. Vriens PW, van de Linde P, Slotema ET, Warmerdam PE, Breslau PJ. Computed tomography severity index is an early prognostic tool for acute pancreatitis. J Am Coll Surg. 2005;201(4):497–502. doi:10.1016/j.jamcollsurg.2005.06.269.

    Article  PubMed  Google Scholar 

  20. Ambrosetti P, Becker C, Terrier F. Colonic diverticulitis: impact of imaging on surgical management—a prospective study of 542 patients. Eur Radiol. 2002;12(5):1145–1149. doi:10.1007/s00330-001-1143-y.

    Article  PubMed  CAS  Google Scholar 

  21. Rao PM, Rhea JT, Novelline RA, Mostafavi AA, McCabe CJ. Effect of computed tomography of the appendix on treatment of patients and use of hospital resources. N Engl J Med. 1998;338(3):141–146. doi:10.1056/NEJM199801153380301.

    Article  PubMed  CAS  Google Scholar 

  22. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629.

    PubMed  CAS  Google Scholar 

  23. Thoeni RF, Cello JP. CT imaging of colitis. Radiology. 2006;240(3):623–638. doi:10.1148/radiol.2403050818.

    Article  PubMed  Google Scholar 

  24. Imbriaco M, Balthazar EJ. Toxic megacolon: role of CT in evaluation and detection of complications. Clin Imaging. 2001;25(5):349–354. doi:10.1016/S0899-7071(01)00330-8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jon D. Vogel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

da Luz Moreira, A., Vogel, J.D., Baker, M. et al. Does CT Influence the Decision to Perform Colectomy in Patients with Severe Ulcerative Colitis?. J Gastrointest Surg 13, 504–507 (2009). https://doi.org/10.1007/s11605-008-0732-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-008-0732-3

Keywords

Navigation